A Trial of GH001 in Patients With Treatment-resistant Depression

NCT05800860 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Treatment-resistant Depression

Interventions

DRUG: GH001
DRUG: Placebo

Sponsor

GH Research Ireland Limited